Back to FARALLON CAPITAL MANAGEMENT, L.L.C. FARALLON CAPITAL MANAGEMENT, L.L.C.

TNGXTNGX
14 quarters

Position history for FARALLON CAPITAL MANAGEMENT, L.L.C.FARALLON CAPITAL MANAGEMENT, L.L.C.'s holdings in TANGO THERAPEUTICS INC

Yes. Farallon Capital Management holds 12,277,000 shares of TNGX (Tango Therapeutics), worth $383.8M, as of its Q2 2026 13F filing. It increased the position by 3,179,589 shares (+35.0%) from Q1 2026. Farallon Capital Management has held TNGX since Q4 2024, across 7 quarterly 13F filings. TNGX is 1.8% of Farallon Capital Management's reported 13F portfolio.

Current Value

$383.8M

Current Shares

12.3M

Total Value Change

+$379.9M

Total Shares Change

+12M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
12.3M
+35.0%
$383.8M1.8%$31.26
63
2026-Q1
Decreased
9.1M
-30.4%
$190.3M1.0%$11.50
0
2025-Q4
Increased
13.1M
+21.4%
$115.7M0.5%$8.63
51
2025-Q3
Increased
10.8M
+17.5%
$90.4M0.4%$8.44
42
2025-Q2
Increased
9.2M
+98.6%
$46.9M0.2%$5.01
56
2025-Q1
Increased
4.6M
+15.3%
$6.3M0.0%$1.47
31
2024-Q4
New
4M
-
$12.4M0.1%$3.10
39
2023-Q1
Exited
0
-100.0%
$00.0%$3.92
0
2022-Q4
Decreased
270,000
-10.0%
$2M0.0%$7.25
0
2022-Q3
Unchanged
300,000
0.0%
$1.1M0.0%$3.60
0
2022-Q2
Unchanged
300,000
0.0%
$1.4M0.0%$4.32
0
2022-Q1
Unchanged
300,000
0.0%
$2.3M0.0%$7.75
0
2021-Q4
Unchanged
300,000
0.0%
$3.3M0.0%$10.86
0
2021-Q3
New
300,000
-
$3.9M0.0%$12.03
37

Other major holders of TNGX: RTW INVESTMENTS, LP, BlackRock, Inc., FMR LLC, GOLDMAN SACHS GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used